Nazim Serdar Turhal M.D.

Personal Information Date of Birth: April 5th, 1964 Place of Birth: Eskisehir, Turkey Citizenship: T.R. / U.S.A. Work Address: Tophanelioglu cad. 13/15 Altunizade Istanbul 81190 Office: Unel Apt 251/5 Bagdat Cad Goztepe Istanbul 34728 Telephone: 90 (216) 3580238-39-40 (pbx) Fax: 90(216) 3580237 e-mail: turhal@superonline.com Present Academic Rank and Position:

Professor, Marmara University Medical School Director, Dept. of Internal Medicine,

Division of Oncology, Marmara University Hospital

Education: September 1988 M.D. Univ. of Istanbul

1988-89 Visiting Extern U.C. San Francisco San Francisco, Ca.

1989-90 Surgical Intern Baptist Med. Ctr. Birmingham, Al.

1990-93 Internal Medicine Resident Griffin Hospital (Yale U. Affiliate) Derby, Ct.

1993-96 Hematology-Oncology Fellow Mt.Sinai Med. Center New York, N.Y.

1996-97 Bone Marrow Transplant Fellow Mt. Sinai Med. Center New York, N.Y.

Board Certification:

ECFMG: April 1989 428514-4 FLEX: June 1990 640405501 Internal Medicine (USA): November 1996 158365

Oncology (USA): November 1997 158365 Renewed November 2007 158365 Internal Medicine (Turkish) October 1996 42248-46399 Oncology (Turkish) August 1997 43335-46399

Oncology (European) January 2000

mailto:turhal@superonline.com

2

Medical Licensure New York 192309 Tennessee 034693 Honors: 2000 Technology Transfer Grant Recipient ESMO-NCI Milan

1994-95 Chief Fellow Mt. Sinai Med. Center

1987 Representative Class of '89 Warsaw, Poland

1986 Representative Class of '88 K. City, Kuwait

1981-82 American Field Service Student Nebraska, USA

Previous Professional Positions and Appointments Outside of present position I covered numerous physicians and locations in United States for locum tenants appointments since 1997. Education-Teaching

1. Weekly junior medical student bed side teaching 3 hours 1997-present 2. Quarterly junior medical student oncology lectures 8 hours 1997-present 3. Biweekly Oncology seminars to fellows and residents 4 hours 1997-present 4. Weekly Cancer care meetings with nurses,

residents, fellows, psychologists 4 hours 1997-present 5. Weekly junior medical student modular

educational activities 48 hours 1999-present Postdoctoral Fellows Working or Worked For Me

Gul Atalay M.D. 6 years Med. Oncology Faysal Dane 4 years Med. Oncology Devrim Cabuk 2 years Med. Oncology Mehmet Teomete 2 years Med. Oncology Mahmut Gumus 3 years Med. Oncology Mehmet Aliustaoglu 3 years Med. Oncology Meltem Ekenel 3 years Med. Oncology

Salih İyikesici 3 years Med. Oncology Hatice Yildiz 1 year Data Management Esen Guzet 2 years Data Management Neslihan Doygun 2 years Data Management

Fatih Ergun 2 years Data Management Sibel Çelebioğlu 1 year Data Management

3

Institutional, Departmental, and Divisional Administrative Responsibilities, Committee Memberships, and Other Activities Director Division of Oncology 1998-present Credentialing Coordinator Department of Medicine 2000-present Faculty of Pharmacy Medical Lectures Coordinator Medical School 2000 Transfusion Committee Marmara Univ. Hospital 1999 Hospital Formulary Marmara Univ. Hospital 1999 Professional and Society Memberships American Society of Clinical Oncology 1999 European Society of Medical Oncology 1999 Balkan Union of Oncology 1998 American College of Physicians 1998

Turkish Oncological Society 1998 Intramural Presentations

1. Weekly Cancer Grand Rounds 1 hour 1998- 2. Weekly multidisciplinary patient care meetings 3 hours 1998- 3. Weekly oncological pathology meetings 2 hours 1998- 4. Quarterly Internal Medicine grand rounds 1 hour 1998- 5. Weekly Thoracic malignancies multidisciplinary

patient care meetings 2 hours 1999- 6. Oncology Nursing Regional Conference 31 hours 2000 7. Surgical Oncology Nursing PhD Program 12 hours 2000 8. Oncology Nursing National Conference 32 hours 2001

Clinical Practice, Interests and Accomplishments Active member of EORTC Gastrointestinal tumors study group. Research Interests

Prognostic factors and therapy in Gastrointestinal malignancies Research Grants Awarded

1. Marmara University research grant for mamosintigraphy project 2. European Society for Medical Oncology Technology Transfer grant

Community Activities

1. “Living with Cancer” television series at Medical Channel 2001- 02 2. “Living with Cancer” column at weekly Gazette Kadikoy 2001- 03

4

Bibliography International Peer Reviewed Journal Publications:

2.3.1.1. Turhal N, Sullivan MB, Blakemore WS. Thyroglossal Duct Cyst. South Med J, 1990, 83:8, 983-4. 2.3.1.2. Turhal N, DeLuca VA Jr. Ulcerative Colitis and Scleroderma. A coincidental relationship. J Clin Gastroenterol. 1994, 18:3, 218-9.

2.3.1.3. Turhal NS, Henehan MD, Kaplan KL. Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am J Hematol 1998, 57:1, 51-56. 2.3.1.4. Turhal NS. Cyclosporin A and Imipenem Associated Seizure Activity in Allogeneic Bone Marrow Transplantation Patients. Journal of Chemotherapy 1999 11(5): 410-413.

2.3.1.5. Turhal NS, Erdal S, Karacay S. Efficacy of the Treatment to Relieve Mucositis Induced Discomfort. Supportive Care in Cancer 2000 8(1): 55-58. 2.3.1.6. Turhal NS. Pancreatic Duct Cell Carcinoma with Positive In-111 Octreotide Uptake. Journal of Experimental and Clinical Cancer Research 2000 19(2): 241-244. 2.3.1.7. Turhal NS. Sumatriptan overdose in episodic cluster headache: a case report of overuse without event. Cephalalgia. 2001 21:700. 2.3.1.8. Turhal NS, Rand J. Antiphospholipid syndrome in HIV infection - Report of four cases and review of literature. Allergy & Clinical Immunology International 2001 13(6):1-4. 2.3.1.9. Duman D, Turhal NS, Duman DG, M.D. Fatal Aplastic Anemia during Treatment with Ketoconazole. American Journal of Medicine 2001, 111:9 2.3.1.10. Turhal NS. Two cases of advanced renal cell cancer with prolonged survival of 8 and 12 years. Japanese Journal of Clinical Oncology 2002 32(4): 152-153 2.3.1.11. Turhal NS, Gumus M, Atalay G, Aliustaoglu M, Kabakas F, Karamanoglu A, Sengoz M. Outpatient cancer care in a Turkish university hospital. Journal of BUON 2002 7(4): 397-398. 2.3.1.12. Turhal NS, Efe B, Gumus M, Aliustaoglu M, Karamanoglu A, Sengoz M. Patient satisfaction in the outpatients` chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey. BMC Cancer 2002 2(1): 30-33. 2.3.1.13. Turhal NS, Aliustaoglu M, Gurses I, Gumus M, Atalay G, Karamanoglu A, Sengoz M. Neoplastic diseases prevalence in a Turkish university hospital. Journal of BUON 2003 8(1): 45-48. 2.3.1.14. Karamanoglu A, Yumuk PF, Gumus M, Aliustaoglu M, Selimen D, Sengoz M, Turhal NS. Port needles: Do they need to be removed as frequently in infusional chemotherapy? Journal of Infusional Nursing 2003 26(4):239-242. 2.3.1.15. Abacıoglu U, Sengoz M, Yumuk F, Salepci T, Turhal NS. Cisplatin and etoposide in extra pulmonary small cell cancer. Tumori 2003 89(3): 274-277. 2.3.1.16. Yumuk PF, Abacioglu U, Caglar H, Gumus M, Sengoz M, Turhal NS. Outcome of

5

rectum and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital. J Chemother 15 (6): 603-606, 2003. 2.3.1.17. Turhal NS, Dane F, Dede F, Gumus M, Yumuk PF, Cakalagaoglu F, Savcı D, Karaman M, Gulluoglu B, Turoglu HT. 99m-Tc-MDP Scintimammography to assess angiogenesis in patients with untreated breast cancer. Anticancer Research. 24:1999-2006 (2004)

2.3.1.18. Yumuk PF, Gumus M, Ekenel M, Basaran G, Aliustaoglu M, Topal A, Turhal NS, N. Attitude Toward Genetic Testing in Turkish Society. Genetic Testing 8(2):169-173, 2004 2.3.1.19. Yumuk PF, Aydin SZ, Dane F, Gumus M, Ekenel M, Aliustaoglu M, Karamanoglu A, Sengoz M, Turhal NS. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients. International Journal of Colorectal Disease 19: 609-610, 2004. 2.3.1.20. Bolukbas FF, Kılıc H, Bolukbas C, Gumus M, Horoz M, Turhal NS, Kavalı B. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004, 4:29-32. 2.3.1.21. Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS. Does the Incidence of Anal Canal Cancers Differ in Moslem Societies? International Journal of Colorectal Disease, Clinical and Molecular Gastroenterology and Surgery. 20(1), 76 2004. 2.3.1.22. Aliustaoglu M, Yumuk PF,Gumus M, Ekenel M, Bolukbas F, Mutlu N, Basaran G, Avsar E, Turhal NS. D-Dimer—Can it be a marker for malignant gastric lesions. Acta Oncologica, 2004 Dec 43(8) 770-771. 2.3.1.23. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D’Haese S, Coens C. Clinical and Psychometric validation of a questionnaire module, The EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer, 2004 Oct 40(15): 2260-8 2.3.1.24. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, Caglar H, Sengoz M, Turhal S. What should be the optimal number of lymph nodes dissected in colorectal Cancer surgery? Tumori, 172/03. 11 2004.

2.3.1.25. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T, Aliustaoglu M, Ahiskali R, “Results of paclitaxel (day 1 and 8) and Carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung Cancer”, BMC Cancer, (MS:7372801141679098), 2005 March, 21

2.3.1.26. Abacioğlu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS, “Concurrent chemoradiotherapy with low dose weekly Gemcitabine in stage III non-small cell lung cancer.” BMC Cancer. 2005 Jul, 6;5:71 2.3.1.27. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T, Aliustaoglu M, Ahiskali R. Results of Paclitaxel (day 1 and 8) and carboplatingiven on every three weeks in advanced (stage III-IV) non-small cell lung cancer. BMC Cancer. 2005 Jan 25;5:10. 2.3.1.28. Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS, Does the incidence of anal canal cancers differ in Moslem societes? International Journal of Colorectal Disease 2005 20:76

6

2.3.1.29. Turhal NS, Popov I. Colorectal cancer care in the Balkan countries. Journal of Balkan Union of Oncology Volume 10 No: 2, April-June 2005 189-193 2.3.1.30. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, Caglar H, Sengoz M, Turhal NS, What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori. 2005 Mar-Apr;91(2): 168-72 2.3.1.31. Abacioglu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS, Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer. BMC Cancer, 2005 Jul 6;5:71 2.3.1.32. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. “Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention.” Eur Urol. 2006 Feb; 49(2):7. Epub 2005 Nov 7.

2.3.1.33. Turhal NS, Popov IP. “Colorectal cancer care in the Balkan countries.” J BUON 2005 Apr-Jun;10(2):189-93

2.3.1.34. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. “Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention: Part 2.” Eur Urol 2006 Mar 49(3):578-80.

2.3.1.35 Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. “HPV DNA frequency and subset analysis in human breast cancer patients normal and tumoral tissue samples.” J Exp Clin Cancer Res. 2006 Dec;25(4):515-21. 2.3.1.36. Onol FF, Tandr Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. Part 1: Eur Urol 2006 Feb;49(2): 406-7 2.3.1.37. Onol FF, Tandr Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. Part 2: Eur Urol. 2006 Mar; 49(3):578-80. 2.3.1.38. Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. HPV DNA frequency and subset analysis in human breast cancer patients normal and tumoral tissue samples. Journal of Experimental and Clinical Cancer Research, December 2006, 515-521

2.3.1.39. Komurcu S, Turhal NS, Altundag K, Atahan L, Turna HS, Manavoglu O, Yavuz AA, Ozkok S, Aliustaoglu M, Altinbas M, Pak Y, Cooper R, Yaylaci M, Demirkan B, Sarihan S, Ozdemir F. “Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish Oncology group trial.” Eur J Cancer Care (Engl). 2007 Jan; 16(1):67-73

2.3.1.40. Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal NS, Sengoz M. “Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.” J BUON. 2007 Apr-Jun;12(2):203-8.

7

2.3.1.41. Celikel C, Eren F, Gulluoglu B, Bekiroglu N, Turhal NS. “Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications.” Pathol Oncol Res. 2007:13(3):215-26. Epub 2007 Oct 7.

2.3.1.42. Cabuk D, Basaran G, Celikel C, Dane F, Yumuk PF, Iyikesici MS, Ekenel M, Turhal NS. “Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival.” Oncology. 2007 Nov 15;72(1-2):111-117. 2.3.1.43. Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal NS, Sengoz M. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. Journal of BUON 12: 203-208, 2007 2.3.1.44. Yumuk PF, Dane F, Yumuk VD, Yazici D, Ege B, Bekiroglu N, Toprak A, Iyikesici S, Basaran G, Turhal NS.Impact of body mass index on cancer development. J BUON. 2008 Jan-Mar;13(1):55-59 2.3.1.45. Atasoy BM, Dane F, Yumuk PF, Akgün Z, Turhal NS, Abacioğlu U, Sengöz M. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON. 2008 Jan-Mar;13(1):43-50. 2.3.1.46. Koldas M, Gumus M, Seker M, Seval H, Huyla K, Dane F, Kural A, Gumus A, Salepci T. and NS Turhal, ”Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer,” Clin Lung Cancer., 9(2), 112-115 (2008). 2.3.1.47. Ustaalioglu BB, Gumus M, Bilici A, Seker M, Dane F, Salepci T, S alman T, Aliustaoglu M, Gezen C, Yaylaci M, Turhal NS, Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience. Med. Oncol, 2009 Jun 2. 2.3.1.48. Kefeli U, Dane F, Yumu k PF, Karamanoglu A, Iyikesici M, Basaran G, Turhal NS, Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. Eur J Cancer Care (Engl), 2009 Mar; 18(2), 191-4. 2.3.1.49. Kuscu MK, Dural U, Onen P, Yasa Y, Yayla M, Basaran G, Turhal NS, Bekiroglu N. The association between individual attachment patterns, the perceived social support, and the psychological well-being of Turkish informal caregivers. Psychooncology, 2009 Jan 12. 2.3.1.50. Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, Turhal NS. A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin’s lymphoma: The importance of second opinion. J BUON, 2009 Apr-Jun;14(2):309-11. 2.3.1.51. Kefeli U, Dane F., Yumuk PF, Karamanoglu A, Iyikesici S, Basaran G, and NS Turhal, “Prolonged inerval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer,” Eur J Cancer Care (Engl), 18(2), 191-194 (2009). 2.3.1.52. Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, and NS Turhal, “A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin’s lymphoma: the importance of second opinion,” J BUON, (2009). [basımda]

http://www.ncbi.nlm.nih.gov/pubmed/18404787?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSumhttp://www.ncbi.nlm.nih.gov/pubmed/18404787?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSumhttp://www.ncbi.nlm.nih.gov/pubmed/18404785?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

8

2.3.1.53. Gumus M, Basak O, Ustaalioglu MG, Kiziltan E, Bilici A, Seker M, Erkol B, Salepci T, Mayadagli A, Turhal NS. Factors that Affect Patients’ Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients. Breast Care 2010;5:164–168 2.3.1.54. Dane F, Yumuk PF, Başaran G, Gündüz F, Peker Ö, Turhal NS, A Case of Primary Breast Mantle Cell Lymphoma with Atypical Relapse Patterns and Rewiew of the Literature Journal of BUON Vol: 16 No: 2, 2010 2.3.1.55. Turhal NS, Bas E, Er O, Aliustaoglu M, Seber S, Dane F, Korkmaz T, Soyuer I, Ozkara S, Celikel C. ERCC1 is not expressed in hepatocellular cancer: A Turkish Oncology Group, Gastrointestinal Oncology Subgroup study. Journal of BUON 15: 794-796, 2010 2.3.1.56. Turhal NS. Dane F, Sınav H, Yalçın N, Khorshidi Z, Yalçın ZZ. Anxiety and depression in Turkish breast cancer patients. Journal of BUON 15: 720-725, 2010 2.3.1.57. Korkmaz T, Seber S, Turhal NS. Primary melanoma of the gallbladder. Letter 802 2.3.1.58. Basaran G, Cabuk D, Caglar HB, Gulluoglu B, Kaya H, Seber S, Korkmaz T, Telli F, Kocak M, Dane F, Yumuk PF, Turhal NS. Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years? Med Oncol. 2010 Apr 14. [Epub ahead of print] DOI 10.1007/s12032-010-9516-1.

2.3.1.59. Dane F, Ozturk MA, Gumus M, Guven A, Aliustaoğlu M, Cabuk D, Teomete M, Basaran G, Yumuk PF, Turhal NS. Effi cacy, safety and prognostic features of resected colon carcinoma treated in “real world” practice: a retrospective cohort-study. Journal of BUON 16: 257-264, 2011 2.3.1.60. Bilici A, Dane F, Seker M, Ustaalioglu BB, Aliustaoglu M, Temiz S, Gezen C, Yavuzer D, Aksu G, Mayadagli A, Gumus M, Uygun K, Turhal NS. Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers. Digestive Diseases And Scienses DOI: 10.1007/s10620-011-1721-z 2011. 2.3.1.61. Dane F, Akif Ozturk M, Gumus M, Guven A, Aliustaoglu M, Cabuk D, Teomete M, Basaran G, Fulden Yumuk P, Turhal NS. Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study. J BUON. 2011 Apr-Jun;16(2):257-64. 2.3.1.62. Basaran G, Devrim C, Caglar HB, Gulluoglu B, Kaya H,Seber S, Korkmaz T, Telli, Kocar M, Dane F, Turhal NS. Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years? Medical Oncology: Volume 28, Issue 3 (2011), Page 726-732.

2.3.1.63. Korkmaz T, Seber S, Basaran G, Yumuk PF, Dane F, Kocar M, Telli F, Turhal NS. 5-Flourouracil–Induced Encephalopathy in Parkinson’s disease. International Journal of Hematology and Oncology 2011 vol: 21 Num 1 Page(s): 001-003 2.3.1.64. Abali H, Ata A, Ozdogan M, Turhal NS, Cabuk D, Seyrek E, Coskun HS, Arik Z, Erman M, Celik I. Frequency of comorbid illnesses in cancer patients in Turkey. Journal of BUON 16: 557-560, 2011. 2.3.1.65. Turhal NS, Dane F, Butur S, Kocak M, Telli F, Seber S, Kanitez M, Aktas B, Yumuk PF. Efforts to Validate the Applicability of Established Chemotherapy Treatment in Turkish Cancer Patient. Pharmaceutica Analytica Acta. S14. 2011.

9

2.3.1.66. Okutur K, Korkmaz T, Seber S, Dane F, İlhan M, Turnal NS, Demir G. Weekly Docetaxel, Cisplatin and 5-Flourouracil in the first-line treatment of metastatic gastric cancer. MOJ:1;35-40, 2011. 2.3.1. 67. Turhal NS. Daily life of a Turkish Medical Oncologist. J Oncol Pract 8:164-166, 2012

2.3.1.68. Korkmaz T, Seber S, Okutur K, Basaran G, Yumuk F, Dane F, Oney T, Polat O, Madenci O, Demir G, Turhal NS. Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer. Biomarkers, 2012; Early Online: 1–7 © 2012 Informa UK, Ltd. 2.3.1.69. Turhal NS et al. The Association between Socio-Demographic Parameters and the Use of Complementary Interventions in Cancer Patients in Turkey A Turkish Oncology Group Study. Journal of Cancer Therapeutics and Research, ISSN: 2049-7962, Volume: 1, Issue: 1, 2012 2.3.1.70. Uncu D, Aksoy S, Cetin B, Yetisyigit T, Ozdemir N, Berk V, Dane F, İnal A, Harputluoglu H, Budakoglu B, Koca D, Sevinc A, Cihan Ş, Durnalı AG, Ozkan M, Oztürk M, Işıkdoğan A, Büyükberber S, Benekli M, Köş T, Alkış N, Karaca H, Turhal NS, Zengin N. Anatolian Society of Medical Oncology. Results of Adjuvant FOLFOX regimens in stage III. Colorectal Cancer Patients. Retrospective Analysis of 667 Patients. Oncology 2013.84:240–245 2.3.1.71. Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS. Primary renal carcinoid: Treatment and prognosis. Critical Reviews in Oncology/Hematology-2013 ONCH-1712; No of pages 19. 2.3.1.72. Artac M, Turhal NS, Kocer M, Karabulut B, Bozcuk H, Yalcin S, Karaagac M, Gunduz S, Isik N, Uygun K. Do high-risk features support the, use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. Tumori, 100:143-148, 2014 2.3.1.73. Kani HT, Siykhmbayev A, Demircan N, Banzragch M, Gunes Yegin E, Bicakci Y, Aydin Y, Irmak R, Guney Duman D, Yumuk PF, Dane F, Turhal NS, Bekiroglu N, Ozdogan OC. Benefıcıal Effect of Multıdıscıplınary approach on Survıval ın Hepatocellular Carcınoma Patıents. Journal of Hepatology2014 vol 60. S215-S359, P577. 2.3.1.74. Kocar M, Bozkurtlar E, Telli F, Turhal NS, Kaya H, Kocar H, Yumuk PF. PTEN loss is not associated with trastuzumab resistance in metastatic breast cancer. JBUON 2014; 19(4): 900-905. 2.3.1.75. Yalcin S, Trad D, Yasser AK, Halawani H, Demir OG, Mall R, Meshcheryakov A, Nasr F, Nosworthy A, Osinsky D, Tumanova A, Turhal NS, Tejpar S, Köhne CH. Personalized treatment is beter than one treatment fits all in the management of patients with mCRC: a consensus statement. Future Oncol 2014; 10(16), 2643-2657 2.3.1.76. Tanriverdi O, Yavuzsen T, Akman T, Senler FC, Taskoylu BY, Turhal NS, Komurcu S, Cehreli R, Yaren A, Ozyilkan JCED: Your manuscript entitled The perspective of non-oncologistphysicians on patients with metastatic cancer and palliative care (ALONEStudy): a study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2015 Jun;30(2):253-9. doi: 10.1007/s13187-015-0794-3. PMID: 25631655 [PubMed - in process] 2.3.1.77 Dede F, Civen H, Dane F, Aliustaoglu M, Turhal NS, Turoglu HT, İnanir S. Carbon-14 urea breath test: does it work in patients with partial gastric resection? Ann Nucl Med. 2015 Nov;29(9):786-91. doi: 10.1007/s12149-015-1005-3. Epub 2015 Jul 18. PMID: 26187581 [PubMed - in process]

10

2.3.1.78. Ozturk MA, Dane F, Karagoz S, Tural D, Selcukbiricik F, Demirelli F, Buyukunal E, Ozguroglu M, Turna H, Erdamar S, Celikel CA, Bozkurtlar EB, Yumuk PF, Mandel NM, Turhal NS, Serdengecti S. Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer? Hepatogastroenterology. 2015 Jan-Feb;62(137):59-64. PMID: 25911868 [PubMed - indexed for MEDLINE] 2.3.1.79. Ozturk MA, Dane F, Karagoz S, Tural D, Selcukbiricik F, Demirelli F, Buyukunal E, Ozguroglu M, Turna H, Erdamar S, Celikel CA, Bozkurtlar EB, Yumuk PF, Mandel NM, Turhal NS, Serdengecti S. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial). Turk J Gastroenterol. 2015 Mar;26(2):145-53. doi: 10.5152/tjg.2015.5685. PMID: 25835113 [PubMed - indexed for MEDLINE]

2.3.1.80. Tanriverdi O, Cay-Senler F, Yavuzsen T, Turhal NS, Akman T, Komurcu S, Cehreli R, Ozyilkan O. Perspectives and practical applications of medical oncologists on defensive medicine (SYSIPHUS study): a study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Med Oncol. 2015 Apr;32(4):106. doi: 10.1007/s12032-015-0555-5. Epub 2015 Mar 7. PMID: 25750041 [PubMed - in process] 2.3.1.81. Turhal NS, Akinci F, Haciabdullahoglu Y, Dolmaci M, Sari A, Gurhan N, Mutlu A, Ozdemir F, Artac M, Kilickap S; Cancer Epidemiology and Prevention Committee of Turkish Oncology Group.. Changes in lifestyle upon diagnosis of cancer or other chronic illnesses: A Turkish Oncology Group study. J Health Psychol. 2016 Jul 22. pii: 1359105316658968. [Epub ahead of print] PubMed PMID: 27450678. 2.3.1.82. Artaç M, Çoşkun HŞ, Korkmaz L, Koçer M, Turhal NS, Engin H, Dede İ, Paydaş S, Öksüzoğlu B, Bozcuk H, Demirkazık A. Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study. Clin Genitourin Cancer. 2016 Aug;14(4):e347-53. doi: 10.1016/j.clgc.2016.04.021. PubMed PMID: 27236771. 2.3.1.83. Artaç M, Coşkun HŞ, Dane F, Karabulut B, Korkmaz L, Karaağaç M, Çabuk D, Karabulut S, Faruk Aykan N, Doruk H, Avcı N, Turhal NS. Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study. J Gastrointest Cancer. 2016 Sep;47(3):264-72. doi: 10.1007/s12029-016-9823-7. PubMed PMID: 27126591. 2.3.1.84. Alkan A, Guc ZG, Senler FC, Yavuzsen T, Onur H, Dogan M, Karci E, Yasar A, Koksoy EB, Tanriverdi O, Turhal NS, Urun Y, Ozkan A, Mizrak D, Akbulut H. Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG). Support Care Cancer. 2016 Sep;24(9):3747-55. doi: 10.1007/s00520-016-3202-6. PubMed PMID: 27039206. 2.3.1.85. Tanriverdi O, Yavuzsen T, Turhal NS, Kilic D, Yalcin S, Ozkan A, Uzunoglu S, Uysal-Sonmez O, Akman T, Aktas B, Ulger S, Babacan T, Komurcu S, Yaren A, Cay-Senler F. Depression and socio-economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Eur J Cancer Care (Engl). 2016 May;25(3):502-15. doi: 10.1111/ecc.12315. PubMed PMID: 25828949. 2.3.1.86. Tezcan S, Izzettin FV, Sancar M, Turhal NS, Yumuk PF. Role of clinical oncology

http://www.ncbi.nlm.nih.gov/pubmed/25750041http://www.ncbi.nlm.nih.gov/pubmed/25750041http://www.ncbi.nlm.nih.gov/pubmed/25750041

11

pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer. European Journal of Hospital Pharmacy, Feb 2017, pages 1-4 2.3.1.87. Alkan A, Kaçan T, Avcı N, Türker I, Kaçan SB, Ergen A, Yaşar A, Turhal NS, Şenler FÇ. Nurses’ Knowledge Levels about Port Catheter Care (POCATH Study): a study of the palliative care working committee of the Turkish Oncology Group (TOG) Journal Of Clınıcal And Experımental Investıgatıons Volume 8 • Number 2 • June 2017, pages:74-8 2.3.1.88. Elitas M, Sadeghi S, Karamahmutoglu H, Turhal NS. Microfabricated platforms to quantitatively investigate cellular behavior under the influence of chemical gradients,. Biomedical Physics & Engineering Express, Vol 3, Number 3, June 2017 2.3.1.89. Kuscu A, Topkaya O, Yanar A, Turhal NS. Applicability of end of life needs assessment tool at a multicultural Turkish hospital. Journal of Oncological Sciences, Jul 2017: 1-6. 2.3.1.90. Martin M, Holmes FA, Ejlertsen B, Turhal NS, Charif M, Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology, Nov 2017: 30717-9. 2.3.1.91. Benstead K, Turhal NS, O'Higgins N, Wyld L, Czarnecka-Operacz M, Gollnick H, Naredi P, Eriksen JG. Multidisciplinary training of cancer specialists in Europe.Eur J Cancer. 2017 Sep;83:1-8. 2.3.1.92. Yildiz I, Bilici A, Karadurmuş N, Ozer L, Tural D, Kaplan MA, Akman T, Bayoglu IV, Uysal M, Yildiz Y, Tanriverdi Ö, Yazici O, Sürmeli Z, Turhal NS, Bavbek S, Selçukbiricik F, Koca D, Basaran M. Prognostic Factors for Survival in Metastatic Renal Cell Carcinoma Patients with Brain Metastases Receiving Targeted Therapy. Tumori. Advance online publication, DOI:10.5301/tj.5000635 2.3.1.93. Erdem GU, Dogan M, Sakin A, Oruc Z, Yaman E, Yesil Cinkir H, Uysal M, Bozkurt O, Ozturk B, Aytekin A, Ozcelik M, Bahceci A, Cakiroglu U, Turhal NS, Sahin S, Uncu D, Zengin N. Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncol Res Treat. 2018;41(4):220-225.

National (Turkish) Publications:

2.3.2.1. Turhal NS. “Metastatik meme kanseri yaygın kemik metastazlarında tedavi”, Kanser Gündemi, Türkiye Kanserle Savaş Vakfı, 1998 3(3): 118-121. 2.3.2.2. Turhal NS. “Yetişkin kanser hastalarında transfüzyon tedavisi yaklaşımları” Damla, Kan Merkezleri ve Transfüzyon Derneği Bülteni, 1998 22:4-7. 2.3.2.3. Turhal NS. “Meme kanserinin biyolojik tedavisinde: Herceptin, Academic Hospital 1998 4:16-18.

12

2.3.2.4. Turhal NS, Tanju P, Pekin S. “Serviks kanseri etyolojisine yönelik standart ve gelecek vadeden tarama yaklaşımları” Hekimler Birliği Vakfı, Türkiye Klinikleri, Jinekolojik Obstetrik, 1999 9(3): 215-220. 2.3.2.5. Turhal NS, Akdas A. “Prostat kanserinde gen tedavisi uygulaması ve sorunları” Üroloji Bülteni 1999 10(1): 5-11. 2.3.2.6. Turhal NS. “Lokal ileri evre meme kanserinde neoadjuvan ve adjuvan kemoterapi” Hematoloji-Onkoloji, Güncel Derleme Dergisi, 2001 3(2):123-127. 2.3.2.7. Atalay G, Turhal NS. “Kanserli hastalarda ağrı dışı semptomların palyasyonu: Hıçkırık, disfaji ve dispepsi” Hematoloji-Onkoloji, Güncel Derleme Dergisi, 2001, 3(3): 236-239. 2.3.2.8. Kaya H, Kotiloglu E, Sengoz M, Turhal S, Uneri C. “Aggressive fibromatosis: A case report”. Journal of Marmara University Dental Faculty, 2001 Vol 4(3): 288-90. 2.3.2.9. Basaran G, Ekenel M, Demirkalem P, Cakır T, Gulluoglu B, Gumus M, Dane F, Iyikesici S, Kaya H, Yumuk PF, Turhal NS. “Evre 1 (T1 N0 M0) Meme Kanseri: Patolojik özellikler ve klinik sonuçlar”, Türk Onkoloji Dergisi, 2004 19(2):53-57. 2.3.2.10. Yumuk PF, İyikesici MS, Gumus M, Aliustaoglu M, Dane F, Basaran G, Ekenel M, Abacıoglu U, Turhal NS. “Lokal ileri ve metastatik küçük hücreli dışı akciğer kanseri hastalarının değerlendirilmesi, Marmara Üniverstesi deneyimi“, Türk Onkoloji Dergisi, 2004 19(3): 106-110. 2.3.2.11. Yumuk PF, Turhal NS. “Bir medikal onkolog perspektifinden muskuloskeletal hastalıklarda nükleer tıp” Turkish Journal of Nuclear Medicine 2004, Baskıda

2.3.2.12. Atasoy BM, Dane F, Sarı M, Yumuk PF, Akgün Z, Turhal NS, Abacıoğlu U, ve Şengöz M, “Lokal ileri evre skuamöz hücreli baş ve boyun kanserinde sisplatinle eş zamanlı kemoradyoterapi: Yan etki ve uygulanabilirlik analizi,” Türk Onkoloji Dergisi, 23, 1-11 (2008). 2.3.2.13. Atasoy BM, Dane F, Çağlar H, Tezcanlı E, Cingi A, Abacıoğlu U, Turhal NS, ve C Yeğen, “Rezeke edilebilir lokal ileri evre rektum kanserinde floroprimidin bazlı kemoterapi ile eş zamanlı ameliyat öncesi radyoterapi,” Türk Onkoloji Dergisi, 23, 163-171 (2008). 2.3.2.14. Atasoy BM, Dane F, Kefeli AÜ, Caglar H, Cingi A, Turhal NS, Abacıoglu U, Yegen C. Concomitant chemoradiotherapy with low-dose weekly Gemcitabine for nonmetastatic unresectable pancreatic cancer. The Turkish Journal of Gastroenterology 2011;22(1):60-64

13

Citations: 2.3.3.1. Author(s): Kim JH; Lee SH; Park J; Kim HY; Lee SI; Nam EM; Park JO; Kim K; Jung CW; Im YH; Kang WK; Lee MH; Park K. Title: Extrapulmonary small-cell carcinoma: a single-institution experience. Source: JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2004, Vol 34, Iss 5, pp 250-254 2.3.3.2. Yao JL, Madeb R, Bourne P, Lei J, Yang X, Tickoo S, Liu Z, Tan D, Cheng L, Hatem F, Huang J, Anthony S. Title: Small Cell Carcinoma of the Prostate: An Immunohistochemical Study. Source: American Journal of Surgical Pathology. 30(6):705-712, June 2006 2.3.3.3. Author(s): D. Demellawy, A. Samkari, M. Sur, F. Denardi, S. Alowami. Title: Primary small cell carcinoma of the cecum. Source: Annals of Diagnostic Pathology, Volume 10, Issue 3, Pages 162-165 2.3.3.4. Author(s): Young HK, Ryuk K, Ghap JJ, Myung HR, Sang YH, Hyuk CK, Jin SJ, Tae BS, Jong YO, Ki NL. Title: Extrapulmonary small-cell carcinoma of the liver Source: Journal of Hepato-Biliary-Pancreatic Surgery Oct. 2004 Vol 11, Num 5, 2.3.3.5. Author(s): Vogelsang H., Siewert I.R. Title: Neuroendokrine Tumors of the hindgut Source: Best Practice & Research Clinical Gastroenterology, Volume 19, Issue 5, Pages 739-751 2.3.3.6. Author(s): A. Ferlito, K. Devaney, A. Rinaldo Title: Neuroendocrine neoplasms of the larynx: Advances in identification, understanding, and management Source: Oral Oncology, Volume 42, Issue 8, Pages 770-788 2.3.3.7. Author(s): E. Kurt, C. Sezgin, T. Evrensel, U. Yalcinkaya, O. Kanat, A. Veral, M. Demiray, M. Arslan, B. Karabulut, I. Ercan, E. Goker, O. Manavoglu Title: Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma Source: International Journal of Clinical Practice; 2005; 59 (5), 537–543. 2.3.3.8. Author(s): Chen JW , Yuan L , Hu HH Title: Small cell undifferentiated carcinoma in the epididymis Source: Chinese Medical Journal 2005; 118(16): 1402-1404 2.3.3.9. Author(s): Author(s): Vogelsang H., Siewert I.R. Title: Neuroendokrine Tumoren des Kolons und Rektums, Mit Ausnahme der Appendix Source: MULTİ MODALİTY TREATMENT RESULTS Onkologe 2004-10:1069-1078 2.3.3.10. Author(s): Kim KO; Lee HY; Riyu MH; Shin SJ; Kim MK; Lee KH; Hyun MS; Bae HS; Ryoo HM. Title: Extrapulmonary small-cell carcinoma Source: J Korean Med. Sci. 2006; 21: 833-7 2.3.3.11. Author(s): Lee SS; Lee JL; Riyu HM; Chang HM; Tae WK; Jung SL; Jang SJ; Khang SK; Kang YK Title: Extrapulmonary small cell carcinoma: Single center experience with 61 patients Source: Acta Oncologica, Volume 46, Issue 6 2007 , pages 846 – 851 2.3.3.12. Author(s): M. Yashi, F. Terauchi, A. Nukui, M. Ochi, M. Yuzawa, Y. Hara, T. Morita Title: Small-cell neuroendocrine carcinoma as a variant form of prostate cancer

http://www.springerlink.com/content/102030/?p=a66500c29e3f454cb13296c6cc7cf0bd&pi=0http://service.ilib.cn/Search/Search.aspx?Query=CHEN+Jia-weihttp://service.ilib.cn/Search/Search.aspx?Query=YUAN+Linhttp://service.ilib.cn/Search/Search.aspx?Query=Hu+Hong-huihttp://www.informaworld.com/smpp/title%7Econtent=t713690780%7Edb=allhttp://www.informaworld.com/smpp/title%7Econtent=t713690780%7Edb=all%7Etab=issueslist%7Ebranches=46#v46http://www.informaworld.com/smpp/title%7Econtent=g780594594%7Edb=all

14

recurrence: A case report and short literature review Source: Urologic Oncology: Seminars and Original Investigations, Volume 24, Issue 4, Pages 313-317 2.3.3.13. Author(s): A Barbeaux, L Duck, B Weynand, G Desuter, M Hamoir, V Gregoire, J Baurain, J Machiels Title: Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities Source: Oto-Rhino-Laryngology, 2006; Volume 263, Number 8 / 786-790 2.3.3.14. Author(s): L Kovac, M Gjuric, S Branica, K Dawidowsky, S Seiwerth Title: Small cell neuroendocrine carcinoma in the petrous apex Source: Journal of Laryngology & Otology (2006), 120: 74-76 2.3.3.15. Author(s): N. Güler, P. Yumuk, D. Ilguy, V. Olgac, J. Greer Title: Limited Painful Mouth Opening Source: Journal of Oral and Maxillofacial Surgery, Volume 63, Issue 8, Pages 1201-1205 2.3.3.16. Author(s): R. Simon, P. Bourne, Q. Yang, B. Spaulding, P. di Sant'Agnese, H. Wang, H. Xu Title: Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not Source: Human Pathology, Volume 38, Issue 8, Pages 1178-1183 2.3.3.17. Author(s): WT hsueh, WC Su, FF Chen Title: Experiences of Radiotherapy on Extrapulmonary Small Cell Carcinoma Source: 2005, 2, 24. 2.3.3.18. Author(s): DE Demellawy, MA Khalifa, N Ismiil, S Wong, Z Ghorab Title: Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases Source: Diagn Pathol. 2007; 2: 35. 2.3.3.19. Author(s): Yuan ZY, Guan ZZ, Zhou ZM, Xia Y, Huang WZ, Yang XL.Title: Extrapulmonary small cell carcinoma in 52 patients Source: Chinese Medical Journal 2006 Sep; 25(9): 1131-3. 2.3.3.20. Author(s): G. Lima, I. Varkarakis, M. Allaf, S. Fine, L. Kavoussi Title: Small cell carcinoma of epididymis: Multimodal therapy Source: Urology, Volume 66, Issue 2, Pages 432.e19-432.e20 2.3.3.21. Author(s): AF Korcum; G Aksu; M Ozdogan; G Erdogan; O Taskin Title: Stage I small cell carcinoma of the endometrium: survival and management options Source: Acta Obstetricia et Gynecologica Scandinavica, 200 2.3.3.22. Author(s): EB. Rubenstein, DE Peterson, M Schubert, D Keefe, D McGuire, J Epstein, LS. Elting, PC. Fox, C Cooksley, ST. Sonis,Title: Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis Source: Cancer 2004 Volume 100, Issue S9 , Pages 2026 – 2046 2.3.3.23. Author(s): PJ Hancock, JB Epstein, GR Sadler Title: Oral and dental management related to radiation therapy for head and neck cancer Source: J Can Dent Assoc 2003, Vol 69 No: 9, 585-590

http://www.springerlink.com/content/uu186r624w32/?p=f95d7712c8e441eb986a78a59d35d4a5&pi=0http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=363965##http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=363965##http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Yuan%20ZY%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Guan%20ZZ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Zhou%20ZM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Xia%20Y%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Huang%20WZ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlushttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Yang%20XL%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlushttp://www3.interscience.wiley.com/journal/108069517/issuehttp://cda-adc.ca/jcda/vol-69/issue-9/585.pdfhttp://cda-adc.ca/jcda/vol-69/issue-9/585.pdf

15

2.3.3.24. Author(s): DB. McGuire, ME Correa, J Johnson, P Wienandts, Title: The role of basic oral care and good clinical practice principles in the management of oral mucositis Source: Supportive Care in Cancer 2006, Vol 14, No 6, 541-547 2.3.3.25. Palliative Medicine Handbook 3. Dr lan Back 2001 2.3.3.26. Author(s): DJ Harris, MT Knobf, Title: Assessing and Managing Chemotherapy-Induced Mucositis Pain Source: Clinical Journal of Oncology Nursing, 2004, Vol 8, No 6, 622-628 2.3.3.27. Author(s): EMB Costa; MZ Fernandes; LB Quinderé; LB Souza; LP Pinto Title: Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia Source: Pesqui. Odontol. Bras. 2003;17(2):147-50 2.3.3.28. Author(s): D. Alterio, B. Jereczek-Fossa, G. Zuccotti, M. Leon, E. Omodeo Sale, M. Pasetti, T. Modena, P. Perugini, L. Mariani, R. Orecchia Title: Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study Source: International Journal of Radiation Oncology*Biology*Physics, Volume 64, Issue 2, Pages 392-395 2.3.3.29. Author(s): B Quinn, C.M.J. Potting, R Stone, N.M.A. Blijlevens, M Fliedner, A Margulies, L SharpTitle: Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients Source: Eur J Cancer. 2007 doi: 10.1016 / j.ejca. 2007. 09. 014 2.3.3.30. Author(s): MC Guedes; R Weber; MVS Gomez; RB Neto; CG Peralta; RF Bento Title: Influence of evoked compound action potential on speech perception in cochlear implant users Source: Rev. Bras. Otorrinolaringol. vol.73 no.4 São Paulo July/Aug. 2007 2.3.3.31. Author(s): AP Chaves; JAP Gomes; ALH Lima Title: Ocular changes induced by chemotherapy Source: Arq Bras Oftalmol. 2007;70(4):718-25 2.3.3.32. Author(s): Debra J Harris Title: Cancer treatment-induced mucositis pain: strategies for assessment and management Source: Dove Medical Press, Sepp 2006, Vol 2, Iss 3, Page 251-258 2.3.3.33. Author(s): J. M. Blazeby , C. Metcalfe , J. Nicklin , C. P. Barham , J. Donovan, D. Alderson Title: Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia Source: British Journal of Surgery , 2005 Volume 92, Issue 12 , Pages 1502 – 1507 2.3.3.34. Author(s): Y. Dan, J. So, K. Yeoh Title: Endoscopic Screening for Gastric Cancer. Source: Clinical Gastroenterology and Hepatology, Volume 4, Issue 6, Pages 709-716 2.3.3.35. Author(s): Bonnetain F, Bouche O, Conroy T, Arveux P, Raoul JL, Giovanni M, Etienne PL, Mitry E, Seitz JF, Rougier P, Gırault C, Bedenne L, Title: Longitudinal quality of life study in patients with metastatic gastric cancer. Source: Gastroenterol Clin Biol 2005;29:1113-1124

http://www.springerlink.com/content/101182/?p=94680de08f0046049e416f4b80f3c073&pi=0http://ons.metapress.com/content/120389/?p=072deef9802c438e861d0d398bc632de&pi=0javascript:AL_get(this,%20'jour',%20'Eur%20J%20Cancer.');javascript:AL_get(this,%20'jour',%20'Eur%20J%20Cancer.');http://dx.doi.org/10.1016/j.ejca.2007.09.014http://www.dovepress.com/http://www3.interscience.wiley.com/journal/99019821/homehttp://www3.interscience.wiley.com/journal/99019821/homehttp://www3.interscience.wiley.com/journal/112159308/issue

16

2.3.3.36. Author(s): Scurtu R, Groza N, Otel O, Goia A, Funariu G Title: Quality of Life in Patients with Esophagojejunal Anastomosis after total Gastrectomy for Cancer. Source: Rom J Gastroenterol 2005, Vol 14. No 4, 367-372 2.3.3.37. Author(s): Sadighi S, Hohagheghi MA, Montazeri A, Sadighi Z Title: Quality of life in patients with advanced gastric cancer: a randomizad trial comparing Docetaxel Cisplatin 5-FU (TCF) with Epirubicin Cisplatin 5-FU (ECF). Source: BMC Cancer 2006; 1471/2407/6/274 2.3.3.38. Author(s): Olivier B Title: Comment am liorer le pronostic du cancer gastrique en France? Source: Gastroenterol Clin Biol 2005;29:7-10 2.3.3.39. Author(s): P. Costa, J. Carraca, A. Sofia Brito, N. Figueiredo, P. Lages Title: Avaliação multifactorial da qualidade de vida em doentes gastrectomizados por cancro gástrico. estudo piloto de métodos de avaliação Source: J Port Gastrenterol 2006, 13:174-180 2.3.3.40. Author(s): Satoshi M, Adrian AK, Akira T, Yasuhiro K, Takanori M, Junichi S Title: Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Source: Gastric Cancer 2006, Vol 9, No 4, 254-261 2.3.3.41. Author(s): T Conroy, F Marchal, JM. Blazeby Title: Quality of Life in Patients with Oesophageal and Gastric Cancer: An Overview Source: Oncology 2006;70:391-402, 2.3.3.42. Author(s): CC Huang , HH Lien , YC Sung , HT Liu , WC Chie Title: Quality of life of patients with gastric cancer in Taiwan: validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22 Source: Psycho-Oncology, Volume 16, Issue 10 , Pages 945 – 949 2.3.3.43. Author(s): JM Bae, S Kim, YW Kim, KW Ryu, JH Lee, JH Noh, TS Sohn, SK Hong, SM Park, CH You, JH Kim, MK Lee, YH Yun Title: Health-related quality of life among disease-free stomach cancer survivors in Korea Source: Quality of Life Research, 2006, Vol 15 No: 10 / 1587-1596 2.3.3.44. Author(s): P. Lagergren, P. Fayers, T. Conroy, H. Stein, O. Sezer, R. Hardwick, E. Hammerlid, A. Bottomley, E. Van Cutsem, J. Blazeby Title: Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago–gastric junction and the stomach. Source: European Journal of Cancer, Volume 43, Issue 14, Pages 2066-2073 2.3.3.45. Author(s): Y. Yun, S. Kim, K. Lee, S. Park, Y. Kim Title: Age, sex, and comorbidities were considered in comparing reference data for health-related quality of life in the general and cancer populations Source: Journal of Clinical Epidemiology, Volume 60, Issue 11, Pages 1164-1175 2.3.3.46. Author(s): R Pai, C Lin, T Tran, A Tarnawski Title: Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation Source: Biochemical and Biophysical Research Communications 2005, Vol 331, Iss 4, 17, Pages 984-992

http://www3.interscience.wiley.com/journal/5807/homehttp://www3.interscience.wiley.com/journal/116324199/issuehttp://www.springerlink.com/content/100213/?p=0d0f12bc1dc14c71917b82d0516fe3f2&pi=0http://www.springerlink.com/content/100213/?p=0d0f12bc1dc14c71917b82d0516fe3f2&pi=0http://www.sciencedirect.com/science/journal/0006291Xhttp://www.sciencedirect.com/science/journal/0006291Xhttp://www.sciencedirect.com/science?_ob=PublicationURL&_tockey=%23TOC%236713%232005%23996689995%23594878%23FLA%23&_cdi=6713&_pubType=J&_auth=y&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=13daacf6363b18664dd92b7daabcfe57

17

2.3.3.47. Author(s): I Wolf, S Sadetzki, H Kanety, Y Kundel, C Pariente, N Epstein, B Oberman, R Catane, B Kaufman, I Shimon, Title: Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients Source: Cancer, 2006, Vol 106, Iss 4, Pages 966-973 2.3.3.48. Author(s): Dai Shida, Joji Kitayama, Ken Mori, Toshiaki Watanabe and Hirokazu Nagawa Title: Transactivation of Epidermal Growth Factor Receptor Is Involved in Leptin-Induced Activation of Janus-Activated Kinase 2 and Extracellular Signal–Regulated Kinase 1/2 in Human Gastric Cancer Cells Source: Cancer Research 65, 9159-9163, October 15, 2005 2.3.3.49. Author(s): M Koda, M Sulkowska, LK Koda, E Surmacz, S Sulkowski, Title: Overexpression of the obesity hormone leptin in human colorectal cancer Source: Journal of Clinical Pathology 2007;60:902-906 2.3.3.50. Author(s): ER Ropelle, JR Pauli, KG Zecchin, M Ueno, CT Souza, J Morari, MC Faria, LA Velloso, MJA Saad, JBC Carvalheire Title: A Central Role For Neuronal Amp Actıvated Proteın Kınase (Ampk) In Cancer-Induced Anorexıa Source: Endocrinology 2007, Vol. 148, No. 11 5220-5229 2.3.3.51. Author(s): Douglas A Corley Title: Obesity and the rising incidence of oesophageal and gastric adenocarcinoma Source: Gut 2007;56:1493-1494 2.3.3.52. Author(s): M Koda, M Sulkowska, L Kanczuga-Koda, S Cascio, G Colucci, A Russo, E Surmacz, S Sulkowski Title: Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 in human colorectal cancer Source: Annals of Oncology 2007 18(Supplement 6):vi116-vi119 2.3.3.53. Author(s): Petersen SL; Wagner A; Gimsing P. Title: Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Source: AMERICAN JOURNAL OF HEMATOLOGY 1999, Vol 62, Iss 4, pp 228-233. 2.3.3.54. Author(s): Wellwood J; Taylor K; Wright S; Bentley M; Hill G; Phan H; Norris D; Livsey R. Title: Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis. Source: LEUKEMIA & LYMPHOMA 2002, Vol 43, Iss 4, pp 893-896 2.3.3.55. Author(s): Hayes-Lattin B; Blanke CD; Deloughery TG. Title: Pulmonary and intracerebral plasmacytomas in a patient without multiple myeloma: A case report. Source: AMERICAN JOURNAL OF HEMATOLOGY 2003, Vol 73, Iss 2, pp 131-134 2.3.3.56. Author(s): C Pontikoglou; C Fragos; E Kolyvaki; G Samonis a; GD Eliopoulos; HA.Papadaki. Title: Multiple myeloma involving the central nervous system: a report of two cases with unusual manifestations Source: Leukemia and Lymphoma, Volume 46, Issue 5 May 2005 , pages 737 – 741

http://endo.endojournals.org/cgi/rapidpdf/en.2007-0381v1http://endo.endojournals.org/cgi/rapidpdf/en.2007-0381v1http://www.informaworld.com/smpp/title%7Econtent=t713643806%7Edb=allhttp://www.informaworld.com/smpp/title%7Econtent=t713643806%7Edb=all%7Etab=issueslist%7Ebranches=46#v46http://www.informaworld.com/smpp/title%7Econtent=g714008520%7Edb=all

18

2.3.3.57. Author(s): JT Rosal, I Aleman, J Ronquillo, I Puerto, L Rodriguez Title: Glioblastoma multiforme arising in the setting of multiple myeloma Source: Haema 2005; 8(4):704-706 2.3.3.58. Author(s): Asherson RA; Cervera R. Title: Antiphospholipid antibodies and infections. Source: ANNALS OF THE RHEUMATIC DISEASES 2003, Vol 62, Iss 5, pp 388-393 2.3.3.59. Author(s): Cervera R; Asherson RA; Acevedo ML; Gomez-Puerta JA; Espinosa G; de la Red G; Gil V; Ramos-Casals M; Garcia-Carrasco M; Ingelmo M; Font J. Title: Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Source: ANNALS OF THE RHEUMATIC DISEASES 2004, Vol 63, Iss 10, pp 1312-1317. 2.3.3.60. Author(s): Ramos-Casals M; Cervera R; Lagrutta M; Medina F; Garcia-Carrasco M; de la Red G; Bove A; Ingelmo M; Font J. Title: Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): Description of 82 cases. Source: CLINICAL INFECTIOUS DISEASES 2004, Vol 38, Iss 7, pp 1009-1016 2.3.3.61. Author(s): Asherson RA; Shoenfeld Y. Title: Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. Source: JOURNAL OF RHEUMATOLOGY 2003, Vol 30, Iss 2, pp 214-219 2.3.3.62. Author(s): P Hopwood Title: Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer Source: Current Opinion in Oncology. July 2005, 17(4):340-344, 2.3.3.63. Author(s): A MacArthur, CD Bajdik, JJ Spinelli, C Kim-Sing, RP Gallagher Title: Predicting interest in genetic counseling and testing for cancer susceptibility: The British Columbia Family Cancer Survey Pilot Study Source: BC Medical Journal Volume 48, Number 5, June 2006, page 222-225

2.3.3.64. Author(s): U. Gallkowski, H Muller, S. Manekeller, J. Boese-Landgraf, S. Ridwelski Title: Umgang und Pflege implantierter Portkathetern bei Tumorpatiaenten – ein interdisziplinres Problem Source: Surgical Oncology 2.3.3.65. Author(s): ÖU Yesilbalkan Title: Onkoloji Hastalarında Sık Kullanılan Venöz Giriş Aracı: İmplante Port Kateter Source: C.Ü. Hemşirelik Yüksek Okulu Dergisi 2005, 9 (2) 2.3.3.66. Author(s): KW Jauch, W Schregel, Z Stanga Title: 9 Technik und Probleme der Zugange in der parenteralen Ernahrung Source: Aktuel Ernaehr Med 2007; 32, Supplement 1: S41-S53 2.3.3.67. Author(s): N. Villanueva; E. Esteban; I. Muñiz J. VieitezI L. Olay; I. Jimenez; P. Jimenez; M. Luque; B. Llorente; M. Capelan; E. Estrada; Y. Fernández; J. Fra; A. J. Lacave Title: Radioterapia torácica con 70 Gy concurrente con docetaxel o paclitaxel semanal tras quimioterapia de inducción en pacientes con carcinoma de pulmón no

19

microcítico localmente avanzado. Estudio prospectivo de tolerancia y eficacia Source: Oncología (Barc.) v.29 n.10 Madrid dic. 2006 2.3.3.68. Author(s): EE Vokes, J. E. Herndon, M. J. Kelley, D. Watson, M. G. Cicchetti, M. R. Gren Title: Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial Source: Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 7005 2.3.3.69. Author(s): YS Gouda, HM Kohail, NA Elddeb, AM Omar, MM El-Geneidy, YM Elkerm Title: Randomized Study of Concurrent Carboplatin, Paclitaxel, and Radiotherapy Induction Chemotherapy in Patients with Locally Advanced Non Small cell lung cancer Source: Journal of the Egyptian Nat. Cancer Inst. March 2006, Vol 18, No 1, 73-81 2.3.3.70. Author(s): Rossi P; Di Lorenzo G; Formisano R; Buzzi MG. Title: Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients. Source: HEADACHE 2004, Vol 44, Iss 7, pp 713-718 2.3.3.71. Author(s): K. Paemeleire, A. Bahra, S. Evers, MS Matharu, PJ Goadsby, Title: Medication-overuse headache in patients with cluster headache Source: NEUROLOGY 2006;67:109-113 2.3.3.72. Author(s): S Sitalakshmi, R Karuna, D Prema Title: Do plasma D-dimer levels correlate with disease stage in colonic carcinoma? Source: Indian Journal of Surgery, 2006, Vol 68, Iss 6, Page 306-309 2.3.3.73. Author(s): JIN Xiao-shi Title: The research on the changes of the D-dimer and fibrinogen concentrations in the patients with colorectal carcinoma Source: Journal of Tianjin Medical University 2006, VoI．12．No．3 Sep．404-405 2.3.3.74. Author(s): E Renoult, C Buteau, V Lamarre, N Turgeon, B Tapiero Title: Infectious risk in pediatric organ transplant recipients: Is it increased with the new immunosuppressive agents? Source: Pediatric Transplantation 2005, 9 (4), 470–479 2.3.3.75. Author(s): Wang HX, Jı SQ, Zhu L, Lıu J, Xue M, Dıng L, Duan LN, Yan HM, Chen HR Title: Neurological Complications Following Haploidentical Bone Marrow Transplantation Source: Journal of Experimental Hematology 2005, Vol 13, No 6, 1128-1130 2.3.3.76. Author(s): Atesci FC; Baltalarli B; Oguzhanoglu NK; Karadag F; Ozdel O; Karagoz N. Title: Psychiatric morbidity among cancer patients and awareness of illness. Source: SUPPORTIVE CARE IN CANCER 2004, Vol 12, Iss 3, pp 161-167 2.3.3.77. Author(s): Mehta VK, Poen J, Ford J, Oberhelman H, Vierra MA, Bastidas AJ, Fisher GA. Title: Protracted Venous Infusion 5-Fluorouracil With Concomitant Radiotherapy Compared With Bolus 5-Fluorouracil for Unresectable Pancreatic Cancer Source: American Journal of Clinical Oncology. 2001, 24(2):155-159,

20

2.3.3.78. Author(s): R Wilkowski, M Wolf, V Heinemann Title: Primary Advanced Unresectable Pancreatic Cancer Source: Pancreatic Cancer, 2007, Vol 177, Iss 80-15, Pages 79-93 2.3.3.79. Author(s): S Höcht, T Wiegel, A Siegmann, W Hinkelbein Title: Radiochemotherapy in Unresectable Pancreatic Cancer Source: Front Radiat Ther Oncol. 2004, Vol 38, pp 87-93. 2.3.3.80. Author(s): GJ Chang, MAR Bigas, JM Skibber, VA Moyer Title: Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review Source: Journal of the National Cancer Institute 2007 99(6):433-441 2.33.81. Author(s): P Greco, S Andreola, G Magro, F Belli, G Giannone, GF Gallino, E Leo Title: Potential pathological understaging of pT3 rectal cancer with less than 26 lymph nodes recovered: a prospective study based on a resampling of 50 rectal specimens Source: Virchows Archiv, 2006, Vol 449, No 6, Page 647-651 2.3.3.82. Author(s): Caronna R; Cardi M; Sammartino P; Mangioni S; Pittau G; Scozzafava S; Catinelli S; Chirletti P; Stipa V. Title: Functional results of a personal technique of reconstruction after pancreaticoduodenectomy. Source: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2003, Vol 22, Iss 4, pp 187-189 2.3.3.83. Author(s): JK Aronson Title: A worldwide yearly survey of new data and trends Source: Elsevier, Side Effects of Drugs Annual 26, 2.3.3.84. Author(s): J Shuster Title: ISMP Adverse Drug Reactions Reports Source: Hospital Pharmacy, 2002, Volume 37, Number 3, pp 242–249, 333 2.3.3.85. Author(s): LCS Martinez, NEC Ceballos, EM Carrillo Title: To know the survival in patients with renal cell carcinoma Source: Collegio Mexicano de Urologia, 2002, Vol 17, No 4, pp 187-192 2.3.3.86. Author(s): DE Rapp, WS Reynolds, A Lucioni, GT Bales Title: Surgical technique using AdVance™ Sling placement in the treatment of post-prostatectomy urinary Incontinence Source: International Braz J Urol. 2007, Vol. 33 (2): 231-237, 2.3.3.87. Author(s): G Barbagli, M Lazeri Title: Surgical technique using AdVance™ Sling placement in the treatment of post-prostatectomy urinary Incontinence Source: International Braz J Urol. 2007, Vol. 33 (4): 461-469 2.3.3.88. Author(s): S Suryanarayanan Title: Desıgn, development, and characterızatıon of a prototype dıgıtal mammography system Source: Georgia Institute of Technology, 2006 2.3.3.89. Author(s): Garsten J. Title: The Yale-Affiliated gastroenterology program - Personal note. Source: JOURNAL OF CLINICAL GASTROENTEROLOGY 1996, Vol 22, Iss 4, pp 255-260.

http://www.springerlink.com/content/g32778/?p=e4566535bd9b44ad8f5c8990d3c02df6&pi=0http://www.springerlink.com/content/g32778/?p=e4566535bd9b44ad8f5c8990d3c02df6&pi=0http://www.springerlink.com/content/100455/?p=5a175277f0234be69211c286b36a8ed2&pi=0

21

2.3.3.90. Author(s): Lier H; Thees C; Nadstawek J. Title: Anaesthesia and epilepsy - a review. Source: ANASTHESIOLOGIE & INTENSIV MEDIZIN 2003, Vol 44, Iss 12, pp 857-868 2.3.3.91. Author(s): Lorenzo OA; Fernandez-Monras F; Arago JV; Abaurrea FR. Title: Progressive systemic sclerosis and inflammatory bowel disease. Source: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 2002, Vol 94, Iss 6, pp 372-373. 2.3.3.92. Author(s): Epstein JB; Truelove EL; Oien H; Allison C; Le ND; Epstein MS. Title: Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Source: ORAL ONCOLOGY 2001, Vol 37, Iss 8, pp 632-637. 2.3.3.93. Author(s): Moncoucy X; Hamon R; Diebold MD; Coussinet S; Pennaforte JL; Thiefin G; Cadiot G. Title: Systemic sclerosis and ulcerative colitis. Source: GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 2001, Vol 25, Iss 3, pp 324-325 2.3.3.94. Author(s) Ulusakarya A; Youssef A; Bayle C; Vantelon JM; Munck JN. Title: Plasma cell meningitis after an autograft in a patient with multiple myeloma. Source: LEUKEMIA & LYMPHOMA 1999, Vol 34, Iss 5-6, pp 633-634 2.3.3.95. Author(s): Leleu X; Jouet JP; Plantier I; Zandecki M; Lai JL; Mucha D; Lejeune JP; Bauters F; Facon T. Title: Isolated neurological relapse following stem cell transplantation in plasma cell leukemia: a report of two cases. Source: LEUKEMIA 1999, Vol 13, Iss 2, pp 307-309. 2.3.3.96. Mohammadine E; Benabdellah W; Lahlou MK; Benamr S; Essadel H; Belmahi AM; Abbassi A; Ukkas A; Taghy A; Chad B; Zizi A; Belmahi A. Title: About a pseudo neoplasic colic stenosis preceding systemic scleroderma. Source: ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE 1997, Vol 33, Iss 3, pp 127-131. 2.3.3.97. Author(s): Heymann WR. Title: Advances in the cutaneous manifestations of thyroid disease. Source: INTERNATIONAL JOURNAL OF DERMATOLOGY 1997, Vol 36, Iss 9, pp 641-645 2.3.3.98. Author(s): Kilchenstein W; Muller OA. Title: Progressive systemic scleroderma - Involvement of the gastrointestinal tract. Source: AKTUELLE RHEUMATOLOGIE 1996, Vol 21, Iss 4, pp 184-189 2.3.3.99. Author(s): HEYMANN WR. Title: CUTANEOUS MANIFESTATIONS OF THYROID-DISEASE. Source: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 1992, Vol 26, Iss 6, pp 885-902. 2.3.3.100. Author(s): Rohwer, N. ve ark. “HIF-1alpha determines the metastatic potential of gastric cancer cells,” Br J Cancer., 100(5):772-81 (2009). 2.3.3.101. Author(s): Casado, E. ve ark. “UFT (tegafur-uracil) in rectal cancer,” Ann Oncol., 19(8):1371-8, Review, (2008).

22

2.3.3.102. Author(s): 1. Akil, N. ve ark., “High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study,” Br J Cancer, 5;99(3):404-7 (2008)

2.3.3.103. Author(s): Liang, W. Ve ark., “Hypothetic association between human papillomavirus infection and breast carcinoma,” Med Hypotheses., 70(2):305-7 (2008).

2.3.3.104 Author(s): Cazzaniga, M. ve ark., “Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis,” Breast Cancer Res Treat., 114(3):599-605 (2009).

2.3.3.105. Author(s): Mendizabal-Ruiz, A.P. ve ark., “Low frequency of human papillomavirus DNA in breast cancer tissue,” Breast Cancer Res Treat., 114(1):189-94 (2009).

2.3.3.106. Author(s): Amarante, M.K. ve ark., “The possible involvement of virus in breast cancer,” J Cancer Res Clin Oncol., 135(3):329-37 (2009).

2.3.3.107. Author(s): Sun, L. Ve ark., “In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites,” J Exp Clin Cancer Res., 27:35 (2008).

2.3.3.108. Author(s): He, Q. Ve ark., “The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma,” Mol Biol Rep., 36(4): 807-12 (2009).

2.3.3.109. Author(s): Koppie, T.M. ve ark., “Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?,” Cancer., 107(10):2368-74 (2006).

2.3.3.110. Author(s): Govindarajan, A. ve ark., “Lymph node evaluation in early-stage colon cancer,” Clin Colorectal Cancer., 7(4):240-6 (2008).

2.3.3.111. Author(s): York Health Economics c o n s o r t ı u m, Department Of Health, Bowel Cancer Services: Costs and Benefits Literature Review, York Health, April 2007

2.3.3.112. Author(s): Tzanopoulou, S. ve ark. “Synthesis, characterization, and biological evaluation of M(I)(CO)(3)(NNO) complexes (M = Re, Tc-99m) conjugated to 2-(4-aminophenyl) benzothiazole as potential breast cancer radiopharmaceuticals”, Journal Of Medicinal Chemistry, 49, 5408-5410 (2006).

2.3.3.113. Author(s): Richardson, G. ve ark. “Chemotherapy induced diarrhea,” J Oncol Pharm Pract., 13(4):181-98. Review (2007).

23

International Abstracts:

2.4.1.1. Vassallo P, Pearson WN, Turhal N. The diagnostic role of transesophageal echo (TEE) in patients with pulmonary emboli but no obvious embolic source. Chest, 1993, 104:2, 141S. 2.4.1.2. Terk M, Turhal N, Mandeli J, et al: Long-term follow-up of combined modality therapy for unresectable pancreatic cancer. Proceedings of American Society of Clinical Oncology 1996, 16, 307a. Atıflar: 3 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=4331184910065725847 2.4.1.3. Turhal NS, Bruckner HW. Neoadjuvant treatment of gastric and gastroesophageal cancers. Journal of Balkan Union of Oncology 1998, 3:49. 2.4.1.4. Turhal NS, Isola L, Scigliano E, Vlachos A, Fruchtman S. A study of cyclosporine A and imipenem associated grand mal seizures in allogeneic bone marrow transplantation (BMT). Annals of Oncology 1998 9:140. Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=5108787028439853198 2.4.1.5. Erdal S, Karacay S, Turhal NS. Symptomatic Treatment of Chemotherapy Induced Mucositis. Anti-Cancer Treatment 1999 9:259. 2.4.1.6. Turhal NS, Ekenel M, Ozgan A, Bekiroglu N. Attitude Toward Genetic Testing for Cancer Risk Assessment in Turkish Society. European Journal of Gynecological Oncology 1999 20(Supp): 121-122. 2.4.1.7. Turhal NS, Kabakas F, Atalay G, Karamanoglu A. Outpatient Cancer Care in a Turkish University Hospital. Proceedings of American Society of Clinical Oncology 1999, 1652. B. DOÇENTLİK SONRASI 2.4.1.8. Salepci T, Turhal NS. Cisplatin and etoposide in extra pulmonary small cell cancer. Proceedings of American Society of Clinical Oncology 2043, 2000. 2.4.1.9. Turhal NS, Gurses I, Akbaba P. Neoplastic disease prevalence during 1998-99 in Marmara University hospital in Istanbul Turkey. Proceedings of American Society of Clinical Oncology 1773, 2000 2.4.1.10. Guler N, Yucel I, Ozet A, Bilkay BC, Erkisi M, Onur H, Buyukunal E, Turhal S, Firat D. Vinorelbine, Epirubicin and 5 FU combination in the first line treatment of metastatic breast carcinoma. Annals of Oncology 2000 11(4): 137.

http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=4331184910065725847http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=5108787028439853198

24

2.4.1.11. Abacıoglu U, Sengoz M, Atasoy B, Turhal S. A pilot study of low dose weekly gemcitabine and concurrent radiation in patients with locally advanced pancreatic cancer. The third annual global oncology young investigators´ meeting. 2001. 2.4.1.12. Sengoz M, Caglar H, Abacıoglu U, Atasoy B, Turhal S, Gulluoglu B. Patient characteristics and treatment results of postoperatively irradiated breast cancer patients. The Breast Journal 2001 7(5): 42. 2.4.1.13. Atalay G, Gumus M, Aliustaoglu M, Turhal NS. The method of detection and its relationship with the disease stage in Turkish breast cancer patients. The Breast Journal 2001 7(5): 47 2.4.1.14. Dincbas FO, Koca S, Altınel A, Hancılar T, Cavusoglu M, Turhal S, Uskent N, Ozguroglu M, Okkan S. Continuous accelerated hyperfractionated radiotherapy (CHART) plus chemotherapy (CT) with vinorelbine (VB) and cisplatinum (CDDP) in locally advanced NSCLC (TOG-011 study). European Journal of Cancer 2001 37(6): S53 2.4.1.15. Gumus M, Atalay G, Aliustaoglu M, Guler S, Ekenel M, Karamanoglu A, Turhal NS. Attitude toward genetic testing in Turkish society. European Journal of Cancer 2001 37(6): S237. 2.4.1.16. Gumus M, Atalay G, Aliustaoglu M, Karamanoglu A, Turhal NS. Outcome of patients after adjuvant treatment in stage B2/C colon cancer in Istanbul. Twelfth International Congress on Anti-Cancer Treatment. Proceeding Book, February 2002: 150. 2.4.1.17. Aliustaoglu M, Gumus M, Atalay G, Sengoz M, Abacıoğlu U, Karamanoglu A, Turhal NS. The survival characteristics of the stage IIIB and IV non small cell lung cancer patients in Marmara University Hospital in Istanbul, Turkey. Twelfth International Congress on Anti-Cancer Treatment. Proceeding Book, February 2002: 124. 2.4.1.18. Atalay G, Gumus M, Aliustaoglu M, Turhal NS. Predictive factors associated with axillary lymph node metastasis (ALNM) in T1, T2 and T3 breast carcinomas. European Journal of Cancer 2002 38(3): S115. 2.4.1.19. Karamanoglu A, Yumuk PF, Gumus M, Aliustaoglu M, Selimen D, Sengoz M, Turhal NS. Port needles need not be removed as frequently in infusional cancer chemotherapy, our experience in a university hospital in Istanbul, Turkey. Bone Marrow Transplantation 2002 29(2): S275. 2.4.1.20. Gumus M, Aliustaoglu M, Atalay G, Dane F, Caglar H, Sengoz M, Turhal NS. The extension of nodal sampling in colorectal cancer patients in Marmara University Hospital, Istanbul. Proceedings of ASCO Volume 21, 2002: 133b. 2.4.1.21. Turhal NS, Efe B, Gumus M, Aliustaoglu M, Karamanoglu A, Sengoz M. Patient satisfaction in Marmara University outpatient chemotherapy unit in Istanbul. Proceedings of ASCO Volume 21, 2002: 252b. Atıflar: 1 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10755444610255035949 2.4.1.22. Aliustaoglu M, Atalay G, Gumus M, Turhal NS. Outcome of adjuvant treatment in elderly Turkish breast cancer patients. Proceedings of ASCO Volume 21, 2002: 259b. 2.4.1.23. Dane F, Turhal NS, Gumus M, Dede F, Cakaloglu F, Savci D, Gulluoglu B, Kayahan

http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10755444610255035949

25

M, Turoglu T. 99m-Tc-MDP scintimammography to assess angiogenesis in patients with untreated breast cancer. Proceedings of ASCO Volume 21, 2002: 291b. 2.4.1.24. Aliustaoglu M, Yumuk F, Gumus M, Ekenel M, Bolukbas F, Bolukbas C, Atalay G, Mutlu N, Turhal NS. Plasma D-dimer levels in patients with benign and malignant gastric lesions. Annals of Oncology 2002 Vol 13 (Supp 5): 190. 2.4.1.25. Atalay G, Gumus M, Aliustaoglu M, Abacıoglu U, Sengoz M, Gulluoglu B, Turhal NS. Outcome of Turkish breast cancer patients who received epirubicin based adjuvant chemotherapy. Annals of Oncology 2002 Vol 13 (Supp 5):44. 2.4.1.26. Ekenel M, Atalay G, Gumus M, Yumuk F, Aliustaoglu M, Karamanoglu A, Turhal NS. Incidence of chemotherapy induced amenorrhea in premenopausal Turkish breast cancer patients. Fourteenth International Congress on Anti-Cancer Treatment Proceeding Book, February 2003: 159. 2.4.1.27. Ekenel M, Atalay G, Gumus M, Yumuk F, Aliustaoglu M, Karamanoglu A, Turhal NS. Outcome of breast cancer patients after adjuvant therapy in Istanbul, Turkey. Fourteenth International Congress on Anti-Cancer Treatment Proceeding Book, February 2003: 160 2.4.1.28. Aydin SZ, Yumuk PF, Ekenel M, Gumus M, Aliustaoglu M, Karamanoglu A, Sengoz M, Turhal NS. The absence of irinotecan associated acute diarrhea with atropine premedication. Proceeding Book, 205-206, 14th International Congress on Anti-Cancer Treatment, Paris, France, 1-4 February, 2003. 2.4.1.29. Turhal NS, Gumus M, Ekenel M, Guzet E, Yumuk F, Avery B. Prognostic factors and treatment outcomes of adjuvant breast cancer patients in two locations: Tennessee USA and Istanbul Turkey. Proceedings of ASCO Volume 22, 2003: 556. 2.4.1.30. Komurcu S, Turhal NS, Altundag K, Atahan L, Savas-Turna H, Manavoglu O, Yavuz AA, Ozkok S, Aliustaoglu M, Altınbas M, Pak Y, Cooper R, Yaylacı M, Demirkan B, Engin K, Ozdemir F. A clinical evaluation of transdermal fentanyl in adults with cancer pain: Phase IV, multicentre trial. Supportive Care in Cancer 2003 11(6): A39. 2.4.1.31. Aliustaoglu M, Gumus M, Yumuk F, Ekenel M, Karamanoglu A, Sengoz M, Turhal NS. The survival characteristics of the stage IIIB and IV non small cell lung cancer patients in Marmara University hospital in Istanbul, Turkey. Lung cancer 2003 Vol 41 Supp:2 S94.

2.4.1.32. Dane F, Iyikesici S, Gumus M, Yumuk PF, Ekenel M, Atalay G, Karamanoglu A, Turhal NS. Adjuvant treatment outcome of high risk stage II and III colon cancer patients treated in Marmara University, Istanbul. Proceeding Book, 206-207, 15th International Congress on Anti-Cancer Treatment, Paris, France, 9-12 February, 2004 p247. 2.4.1.33. Gunduz F, Yumuk PF, Dane F, Peker O, Ekenel M, Iyikesici S, Atalay G, Turhal NS. Mantle cell lymphoma presenting as a breast mass. Proceeding Book, 206-207, 15th International Congress on Anti-Cancer Treatment, Paris, France, 9-12 February, 2004 p211. 2.4.1.34. Dane F, Yumuk PF, Turhal NS, Ekenel M, Basaran G, İyikesici S, Tecimer C. Folfox4 in metastatic colorectal cancer (MRC) patients who progressed after infusional 5FU/Irinotecan based combination regimens. Proceedings ASCO Volume 23, 2004:3729. 2.4.1.35. Aliustaoğlu M, Gumus M, Midi A, Celikel C. A, Ekenel M, Yumuk PF, Basaran G, Turhal NS. Prognostic value of thymidylate synthase and cox-2 expression in colorectal cancer patients tumors. Proceedings ASCO Volume 23, 2004:3731

26

2.4.1.36. Cabuk D, Yumuk PF, Abacioglu U, Demir G, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS. Is the incidence of anal cancers different in Moslem societies. Proceedings ASCO Volume 23, 2004:4233 2.4.1.37. Abacioglu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS. Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitebine (G) in stage III non-small cell lung lung cancer (NSCLC). Proceedings ASCO Volume 23, 2004:7318 2.4.1.38. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, T. Selepci, Aliustaoglu M, Ekenel M, Ahiskali R. Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC). Proceedings ASCO Volume 23, 2004:7321 2.4.1.39. Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Ekenel M, Basaran G, Dane F, Kaya H, Barisik N, Turhal NS; Human papilloma virus: Is it a new etiological factor in breast cancer?. Proceedings ASCO Volume 23, 2004:9635 2.4.1.40. Turhal NS, Popov I. Colorectal cancer care in Balkans. Procedings of Balkan Union of Oncology Educational Book 2004 C-109 2.4.1.41. Basaran GA, Ekenel M, Demirkalem P, Cakır T, Gulluoglu B, Gumus M, Dane F, İyikesici S, Yumuk F, Turhal S. Clinical outcome of breast cancer patients with pT1N0M0 disease. Annals of Oncology 2004 15(3):257P, iii68. 2.4.1.42. Dane F, Turhal NS, İyikesici S, Gumus M, Yumuk PF, Basaran G, Ekenel M, Avery B. Clinical features and adjuvant treatment outcomes of colon cancer in two outpatient populations of Knoxville Tennessee and İstanbul Turkey. Annals of Oncology 2004 15(3): 355P, iii95 2.4.1.43. Iyikesici S, Turhal NS, Yumuk PF, Dane F, Gumus M, Basaran G, Ekenel M, Avery B. Treatment outcomes in non-small cell lung cancer patients: Comparison between Marmara University, İstanbul Turkey and Knoxville Tennessee. Annals of Oncology 2004 15(3): 741, iii195. PROFESÖRLÜK SONRASI 2.4.1.44. İyikesici MS, Kefeli U, Basaran G, Dane F, Ekenel M, Yumuk PF, Turhal NS, The prognostic impact of body mass index (BMI) in early breast cancer (BC) patient (pts) Proceedings ASCO Volume 23, 2005:882 2.4.1.45. Yumuk PF, Yumuk VD, Yazici D, Ege B, Bekiroglu N, Dane F, Iyikesici S, Basaran G, NS Turhal, “The impact of body mass index on cancer: A Hospital-based study,” 14th European Congress on obesity, Blackwell Publishing, Volume 6, Supplement 1, Page 82 (Abstract 256), Athens, 2005. 2.4.1.46. Basaran G, Dane F, Iyikesici S, Ekenel M, Yumuk PF, Turhal NS, Clinical and pathological characteristics of early breast cancer (EBC) patients

27

2.4.1.47. Cabuk D, Basaran G, Yumuk PF, Celikel C, Dane F, İyikesici MS, Ekenel M, Turhal NS, VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival. Proceedings ASCO Volume 23, 2005:4040 2.4.1.48. Gumus M, Palak B, İyikesici S, Yumuk PF, Seker M, Topal A, Dane F, Salepci T, Yayla A, Turhal NS, Outcome of elderly patients with advanced non-small cell lung cancer. Proceedings ASCO Volume 23, 2005:7345 2.4.1.49. Yumuk PF, Turhal NS, Ahiskali R, Gumus M, Hatabay N, Turken O, Ozkan A, Salepci T, Aliustaoglu M. P53 or Her2/neu as prognostic factors in advanced non-small-cell lung cancer treated with paclitaxel. 11th World Conference on Lung Cancer, Barcelona, Spain. 3-6 July 2005. 2.4.1.50. Iyikesici MS, Yumuk PF, Dane F, Ekenel M, Basaran G, Turhal NS, Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital. 11th World Conference on Lung Cancer, Elsevier, Volume 49 Supp 2, S249, Barcelona, Spain. 3-6 July 2005. 2.4.1.51. İyikesici M, Yumuk PF, Dane F, Ekenel M, Basaran G, Turhal NS, Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey. Abstract of the 11 th World Conference on Lung Cancer, Elsevier Volume 49 Supp 2, 2005: S249 2.4.1.52. Atasoy BM, Abacioglu U, Ozgen Z, Dane F, Yumuk PF, Akgun Z, Ozden S, Mayadagli A, Turhal NS, Sengoz M. Tolerability assessment of urasil-tegafur (UFT)/folinic acid (FA) as concurrent chemoradiation (CRT) in adjuvant rectal cancer treatment. Marmara University School of Medicine, Istanbul, Turkey; Lutfi Kirdar Kartal State Hospital, Istanbul, Turkey. Proceedings ASCO Volume 24 2006:13559 2.4.1.53. Dane F, Gumus M, Iyikesici MS, Yumuk PF, Basaran G, Atasoy BM, Abacioglu U, Cabuk D, Teomete M, Turhal NS, Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital, Istanbul, Turkey. Proceedings ASCO Volume 24 2006:13584 2.4.1.54. Yalcin B, Aydin F, Zengin N, Ilhan M, Isikdogan A, Aykan F, Demir G, Celik I, Turhal NS, Icli F, Akbulut H. The clinicopathological and socioeconomic features of patients with gastric cancer in Turkey (Turkish Oncology Group) Ankara University School of Medicine, Ankara Turkey; Karadeniz Teknik University School of Medicine, Trabzon, Turkey; Ankara Numune Hospital, Ankara, Turkey; Yuzuncu Yil University School of Medicine, Van, Turkey; Dicle University School of Medicine, Diyarbakir, Turkey; Istanbul University, Oncology Institute, Istanbul, Turkey; Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey; Hacettepe University Oncology Hospital, Ankara Turkey; Marmara University School of Medicine, Istanbul, Turkey. Proceedings ASCO Volume 24 2006: 20098 2.4.1.55. Kefeli U, Karamanoglu A, Dane F, Yumuk PF, Iyikesici MS, Basaran G, Turhal NS. Prolonged interval in Prophylactic Heparin Flushing for Maintenance Subcutaneous Implanted Port Care in Patients with Cancer. 17th International Congress on Anti-Cancer Treatment, Abstract Book Page 348, 30th January-2nd February 2006, Paris, France 2.4.1.56. Atasoy BM, Abacioglu U, Ozgen Z, Dane F, Yumuk FP, Akgun Z, Ozden S, Mayadagli A, Turhal NS, M Sengoz, “Concurrent administration of urasil-tegafur and folinic acid with radiation for locally advanced rectum cancer: tolerability and quality of life assessments,” 25th ESTRO Annual Meeting, Leipzig, Radiother Oncol., Vol. 81 (Suppl. 1), S234, Elsevier, Ireland, 2006.

28

2.4.1.57. Atasoy BM, Abacioglu U, Ozgen Z, Dane F, Yumuk PF, Akgun Z, Ozden S, Mayadagli A, Turhal NS, Sengoz M. Concomitant administration of uracil-tegafur (UFT) and folinic acid (FA) during inradiation for locally advanced rectal cancer: tolerability assessment. 6th Congress Balkan Union of Oncology, 13-16 September 2006, Sofia, Bulgaria, 58:OP80, 2.4.1.58. Dane F, Gumus M, Iyikesici S, Basaran G, Ozturk A, Atasoy BM, Abacioglu U, Cabuk D, Teomete M, Turhal NS, Division of Medical Oncology, Marmara University Hospital, Istanbul, Turkey. Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy. 6th Congress Balkan Union of Oncology, 13-16 September 2006, Sofia, Bulgaria, 61:PP93. 2.4.1.59. Dane F, Yumuk PF, Gumus M, Iyikesici S, Tufan A, Basaran G, Cabuk D, Ozturk A, Erdem R, Teomete M, Turhal NS, Dept. Of Internal Medicine Division of Oncology, Marmara University Hospital, Istanbul, Turkey. Outcome of unresectable locally advanced and/or metastatic colorectal cancer patients receiving systemic chemotherapy. 6th Congress Balkan Union of Oncology, 13-16 September 2006, Sofia, Bulgaria, 64:PP107. 2.4.1.60. Turhal NS, Dept. Of Internal Medicine Division of Oncology, Marmara University Hospital, Istanbul, Turkey. Integration of Balkan Oncology in International Study Groups: the University of Marmara Experience. 6th Congress Balkan Union of Oncology, 13-16 September 2006, Sofia, Bulgaria, 109:OP251. 2.4.1.61. Cabuk D, Basaran G, Iyikesici S, Ekenel M, Dane F, Teomete M, Gumus M, Aliustaoglu M, Yumuk PF, Turhal NS, Marmara University Hospital, Medical Oncology, Istanbul, Turkey. Outcome of adjuvant treatment in Turkish Breast Cancer (BC) patients (PTS): single institution experience. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/302 2.4.1.62. Yumuk PF, Gumus M, Kaya H, Alam K, Dane F, Gulluoglu B, Salepci T, Barisik N, Basaran G, Turhal NS. Association Between Presence of HPV DNA and P53 in Breast Cancer Patients. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/311 2.4.1.63. Basaran G, Cabuk D, Caglar H, Iyikesici S, Tebessum C, Gulluoglu B, Kaya H, Dane F, Yumuk PF, Turhal NS. Stage I (T1N0M0) Breast Cancer (BC): Pathological Characteristics and Clinical Outcome. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/321 2.4.1.64. Dane F, Yumuk PF, Gumus M, Iyikesici S, Tufan A, Basaran G, Cabuk D, Teomete M, Turhal NS, Marmara University Hospital Department of Oncology Istanbul, Turkey. Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/378 2.4.1.65. Dane F, Gumus M, Yumuk PF, Iyikesici S, Ozturk A, Basaran G, Caglar H, Cabuk D, Teomete M, Turhal NS, Marmara University Hospital Department of Oncology Istanbul, Turkey. Outcome of colon cancer patients receiving adjuvant chemotherapy in Marmara University Hospital. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/384. 2.4.1.66. Atasoy B, Abacioglu U, Ozgen Z, Dane F, Yumuk PF, Akgun Z, Ozden S, Mayadagli A, Turhal NS, Sengoz M. Adjuvant comcomittant administration of Urasil-Tegafur (UFT) and folinic acid (FA) during irradiation for locally advanced rectum cancer: Tolerability assessment. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/401

29

2.4.1.67. Teomete M, Yumuk PF, Iyikesici S, Dane F, Basaran G, Cabuk D, Caglar H, Abacioglu U, Turhal NS. Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/757P 2.4.1.68. Dane F, Topaloglu N, Abul Y, Yumuk PF, Turhal NS, Ceyhan B, Celikel T, Caglar H, Basaran G, Ahiskali R. Interstitial pneumonitis associated with Docetaxel administration. Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/1069 2.4.1.69. Demir G, Zengin N, Yildiz O, Dogusoy G, Aykan F, Er O, Isikdogan A, Turhal NS, Yilmaz U, Yalcin S. The role of lymph nodes on disease free survival in operated gastric cancer (Turkish Oncology Group Study). Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/1100 2.4.1.70. Demir G, Zengin N, Yildiz O, Ozdamar S, Aykan F, Er O, Ilhan M, Turhal NS, Yilmaz U, Yalcin S. Clinical profile of gastric cancer in Turkey: Factors effecting disease free survival and relapse (Turkish Oncology Group Study). Annals of Oncology Abstract Book of the 31st ESMO Congress 29 September – 3 October 2006, Istanbul, Turkey. Volume 17, Supp, 9/1139 2.4.1.71. Basaran G, Guney N, Saip P, Iyikesici S, Kaya H, Yazıcı H, Turhal NS. Serum extracellular domain (ECD) levels, pAkt and MAKP expressions as potential markers for response to trastuzumab base therapy in metastatic breast cancer patients: A Turkish Oncology Group Study. Ann Oncol. 2006 Sept; 17 (Supp 9): ix69–ix92, Abstract 230, İstanbul, 2006. 2.4.1.72. Yumuk PF, Teomete M, Dane F, Cabuk D, Caglar H, Abacioglu U, Basaran G, Turhal NS, Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey. 12 th. World Conference on Lung Cancer. Journal of Thoracic Oncology, Volume 2, Number 8, Supplement 4, August 2007. 2.4.1.73. M. Gumus, F. Dane, S. Kaya, M. A. Ozturk, P. F. Yumuk, B. M. Atasoy, G. Basaran, T. Salepci, M. Yaylaci, N. S. Turhal. The role of adjuvant chemoradiotherapy (CRT) in Turkish patients with gastric carcinoma. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 15159.

2.4.1.74. F. Dane, M. Gumus, A. Ozturk, F. Yumuk, S. Iyikesici, G. Basaran, D. Cabuk, M. Teomete, N. S. Turhal. Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 14588

2.4.1.75. G. Atalay Basaran, D. Cabuk, F. Dane, M. Teomete, S. Iyikesici, E. Meltem,

B. Gulluoglu, H. Kaya, U. Abacıoglu, F. Yumuk, S. Turhal. Clinical outcome of node-negative (NN) breast cancer (BC) patients. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 11102

2.4.1.76. Yumuk PF, Teomete M, Dane F, Cabuk D, Caglar H, Abacioglu U, Basaran G, Turhal NS, Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey. 12 th. World Conference on Lung Cancer. Journal of Thoracic Oncology, Volume 2, Number 8, Supplement 4, August 2007.

30

2.4.1.77. Basaran G, Cabuk D, Teomete M, Gulluoglu B, Kaya H, Dane F, Yumuk PF, Turhal NS, Benefit from adjuvant anthracyclines according to hormone receptor status. Annual Meeting ASCO 2008: 11513 2.4.1.78. Turhal NS, Ulus C, Sari S, Senturk N, Bingol D. Cancer-related knowledge in relatives of cancer patients and general public in İstanbul, Turkey, Annual Meeting ASCO 2008: 20650 2.4.1.79. F Dane, M Gumus, MA Ozturk, D. Cabuk, MB Atasoy, PF Yumuk, G Basaran, MS Iyikesici, M Teomete, U Abacioglu, NS Turhal. Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience. Annual Meeting ASCO 2008: 15103 2.4.1.80. D Cabuk, G Basaran, H Kaya, B Gulluoglu, M Teomete, F Dane, PF Yumuk, NS Turhal. Clinical outcome of triple-negative (TN) breast cancer (BC). Annual Meeting ASCO 2008: 11526

2.4.1.81. Dane F, Gumus M, Yaman E, Ozturk MA, Sevinc A, Atasoy BM, Cabuk D, Iyikesici S, Yumuk PF, Basaran G, Abacioglu U, Teomete M, NS Turhal, “Demographical Survival and Prognostic Features of Resected Rectal Cancer in Turkish Patients Population,” 18th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists, İstanbul, Hepato-gastroenterology, Vol. 55, (Suppl. 1), OP70, A28, H.G.E. Update Medical Publishing, Greece, 2008.

2.4.1.82. Cabuk D., Basaran G, Teomete M, Dane F, Yumuk PF, Turhal NS, “Clinical/pathological characteristics of breast cancer (BC) patients (pts) with triple-negative (TN) tumors,” 7th Congress of Balkan Union of Oncology (BUON), Proceedings, OP–53, İzmir, 2008.

2.4.1.83. Yumuk PF, Teomete M, Dane F, Cabuk D, Basaran G, Turhal NS, ”Platinum plus vinorelbine (VNR) on days 1 and 8 in advanced non-small cell lung Cancer: Single center results,” 7th Congress of Balkan Union of Oncology (BUON), Proceedings, OP–72, İzmir, 2008.

2.4.1.84. Dane F, Gumus M, Ozturk A, Cabuk D, Basaran G, Turhal NS, “Demographics, survival and prognostic features of resected colon Cancer in Turkish patients population,” 7th Congress of Balkan Union of Oncology (BUON), Proceedings, OP–92, İzmir, 2008.

2.4.1.85. Dane F, Ozturk A, Gumus M, Yumuk F, Basaran G, Turhal NS, ”Survival and prognostic features of stage II and III Rectal Cancer (RC) in Turkish patients population,” 7th Congress of Balkan Union of Oncology (BUON), Proceedings, OP–93, İzmir, 2008.

2.4.1.86. Dane F, Gumus M, Cabuk D, Teomete, M, Yumuk PF, Turhal NS, “Prognostic factors and treatment outcomes in patients with metastatic colorectal cancer (CRC),” 7th Congress of Balkan Union of Oncology (BUON), Proceedings, OP–94, İzmir, 2008.

2.4.1.87. Civen H, Dede F, Dane F, Ustaoglu MA, Turhal NS, Turoglu H, Inanır S, “Does the standard test parameters for C-14 urea breath test